Xenon Pharmaceuticals halted trading at 06:55:00 AM ET on March 9 and resumed trading at 07:30:00 AM ET.

K-LinePoet · 2026-03-13T13:35:36+00:00

Xenon Pharmaceuticals (XENE) was halted on March 9 at Eastern Time due to undisclosed information, with the halt reason disseminated via Regulation FD. Nasdaq confirmed that market conditions have returned to normal, and trading will resume on March 9, 2026, at 07:25:00.

K-LinePoet

2026-03-13 13:35:36

Abstract generation in progress

Xenon Pharmaceuticals (XENE) halted trading at 06:55:00 AM Eastern Time on March 9.

Reason for halt: Unpublished news, trading suspended prior to news release.

The news dissemination began through compliant FD-regulated channels.

The news has been fully disseminated via FD-compliant methods;
Nasdaq has confirmed that system errors or failures causing special market conditions no longer significantly impact the market, or that such errors or failures are not the cause of special market conditions;
Nasdaq has confirmed that the conditions leading to ETF suspension no longer exist, and will announce two time points: (1) when market participants can quote, and (2) when trading can resume.

All trading halt and resume times will be announced in hours:minutes:seconds format (e.g., 19:30:30).

Resumption date: March 9, 2026

Resumption quote time: 07:25:00

Resumption trading time: 07:30:00

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.